MétaCan
Menu
Back to cohort
Record W2944845301 · doi:10.1002/rth2.12204

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review

2019· review· en· W2944845301 on OpenAlexafffund
Jacky K. Yu, Alfonso Iorio, Andrea N. Edginton, Sanjay Ahuja, Ma Teresa Álvarez Román, Ma E. Arrieta, Mikko Arola, Giovanni Barillari, Vinod Balasa, Mark Belletrutti, Rubén Berrueco Moreno, Philippe Beurrier, Cristoph Bidlingmaier, Victor S. Blanchette, Jan Blatný, Santiago Bonanad, Kelsey Brose, Deborah Brown, Paulette C. Byant, Mariana Canaro, Manuela Carvalho, Cristina Catarino, Meera Chitlur, Erin Cockrell, Pratima Chowdary, Marjon H. Cnossen, Peter W. Collins, Michial Coppens, Stacy E. Croteau, Dorina Cultrera, Raimundo de Cristofaro, Emmauelle de Raucourt, Dominique Desprez, Amy L. Dunn, Magda El‐Ekiabi, Barbara Faganel Kotnik, Kathleen Fischer, Brigit Frotscher, Susana Garbiero, R.G. Ruiz, Joan Cox Gill, Carmen Gomez del Castillo, S. Gottstein, Giuseppe Lassandro, Paola Giordano, Daniel P. Hart, Inga Hegemann, Cédric Hermans, Baolai Hua, Nina Hwang, Shannon Jackson, Paula James, Όλγα Κατσαρού, Kaan Kavaklı, Christine L. Kempton, Karim Kentouche, Osman Khan, Rainer Kobelt, Rebecca Kruse‐Jarres, Edward Laane, Eric B. Larson, Riitta Lassila, Adrienne Lee, Man‐Chiu Poon, Jennifer Lissick, Satu Långström, Johnny Mahlangu, Michael Makris, Emmanuela Marchesini, José Mateo, Pacual Marco Vera, Marta Martorell, Tadashi Matsushita, Simon McCrae, Eva Mignot‐Castellano, Caitlin Montcrieff, Philip Maes, Veerle Mondelars, Marlies Bekart, Elena Mora, Juan Cristóbal Morales, Guillaume Mourey, Marie Ann Bertrand, Mariasanta Napolitano, Sergio Siragusa, Claude Négrier, Daniela Neme, Ritta Niinimaki, Johannes Oldenburg, T. Albert, Deborah L. Ornstein, Margarete Ozelo, John C. Panetta, Ellis J. Neufeld, Stephanie P’ng, Kathelijne Peerlinck, Berardino Pollio, Claire Pouplard, Y Gruel, A. Prezotti, Vicky Price, Fitri Primacakti, Mathieu Puyade, Paolo Radossi, Leslie Raffini, Margaret V. Ragni, Savita Rangarajan, Mark T. Reding, Robin Reid, José Restrepo, José Ramirez, Michael Recht, Manuel Rodríguez López, Arlette Ruiz‐Sàez, Mahasen Saleh, Amy Shapiro, Anjali Sharathkumar, Anna Selmeczi, Mindy Simpson, T. DUDLEY SINGLETON, Maria Sol Cruz, Verónica Soto, MacGregor Steele, Werner Streif, Haowei Sun, Bruce Ritchie, Jing Ping Sun, Xiaqin Feng, Takashi Suzuki, Asuza Nagao, Cliff Takemoto, Heather Tapp, Jerry Teitel, Alan Tinmouth, Courtney D. Thornburg, Alberto Tosseto, Oliver Turnstall, Catherine Vézina, Beth Boulden Warren, Allison P. Wheeler, Juan D. Wilches Gutierrez, John K. Wu, Tung Wynn, Renchi Yang, Guy Young, Ezio Zanon, Irena Zupan

Bibliographic record

VenueResearch and Practice in Thrombosis and Haemostasis · 2019
Typereview
Languageen
FieldMedicine
TopicHemophilia Treatment and Research
Canadian institutionsImpactBayer (Canada)McMaster UniversityUniversity of Waterloo
FundersUniversity of Waterloo
KeywordsDosingClotting factorPharmacokineticsMedicineRegimenIntensive care medicineClinical trialPharmacologyInternal medicine

Abstract

fetched live from OpenAlex

The objective of this scoping review is to summarize the current use of pharmacokinetics for tailoring prophylaxis in hemophilia patients switching between clotting factor products. Patients with hemophilia may require switching of clotting factor concentrates due to a variety of factors, but there have been perceived risks associated with switching, such as inhibitor development or suboptimal protection due to inadequate dosing while titrating treatment. Studies that look at patients switching from one clotting factor concentrate to another are categorized in terms of their primary and/or secondary objectives, notably biosimilarity and comparative pharmacokinetic studies and inhibitor development studies. Research on how best to switch concentrates with respect to dosing regimen are lacking, and currently a trial-and-error approach is used for dosing the new factor concentrate. In the future, studies looking at the predictability of pharmacokinetics (PK) of a new factor concentrate based on individual PK knowledge of the original factor concentrate may offer clinical benefit by providing a safer switching approach and protocol.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.019
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.008
Threshold uncertainty score0.023

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.019
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.004
Bibliometrics0.0080.007
Science and technology studies0.0000.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.554
GPT teacher head0.569
Teacher spread0.014 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations21
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueResearch and Practice in Thrombosis and HaemostasisSame topicHemophilia Treatment and ResearchFrench-language works237,207